Gemino Healthcare Finance announced it has provided a $6 million secured revolving line of credit to OMNI Orthopaedics, Inc. (“OMNI”). The proceeds are being used for working capital purposes.

OMNI, headquartered in East Taunton, Massachusetts, was founded in 1999 as a medical device company committed to the design, manufacture and distribution of high quality orthopedic implants and technologies. OMNI’s implant products are prescribed by orthopedic surgeons for their patients who require total knee and hip joint replacement.

Rick Randall, Chief Executive Officer for OMNI stated, “OMNI offers the only commercially available robotic assisted total knee system in the US.  Our proprietary technologies are designed to allow the hospital and physician to demonstrate a quality measure in total joint replacements important to patients and insurers.  We are very pleased to be working with Gemino as one of our financial partners.  This financing supports the expansion of our product portfolio and helps to fund our key growth initiatives.”

Rob Misener, Director for Gemino, said, “OMNI is a world class provider of total joint replacement solutions, and we are excited to provide this credit facility to help support management’s vision for growth.”